CHERRY HILL, N.J.--(BUSINESS WIRE)--Mediscience Technology, Corp. (OTCBB:MDSC) announced that Dr. Fredrick Naftolin joined the company as its Chief Medical Officer effective May 18, 2007. Dr. Naftolin has extensive medical Ob/Gyn health experience with specific interest in female endocrinology, diseases of the female reproductive system, Ob/Gyn research, cancer research, and biochemistry of cancer disease. His consultant responsibilities will include consultation as Chief Medical Advisor of MDSC New York subsidiary BioScopix, Inc. in the development and commercialization of MTC/Bio Autofluorescence-Based Diagnostic Methods and Equipment for human cancer screening and diagnosis, and female hormone level detection: e.g. CD-Ratiometer, CPE.
